|Articles|March 1, 2002

Pharmaceutical Technology

  • Pharmaceutical Technology-03-02-2002
  • Volume 26
  • Issue 3

Drug Safety Concerns Shape Manufacturing Policy

Author(s)Jill Wechsler

FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.
External Link - article-12151.pdf

Articles in this issue

almost 24 years ago

Outsourcing Outlook

almost 24 years ago

Developing Custom Adhesive Systems for Transdermal Drug Delivery

almost 24 years ago

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part II

almost 24 years ago

PDA Task Force Issues Guidelines to Aid Isolator Users

almost 24 years ago

Recent Advances in Semisolid Dosage Forms for Dermatological Application

almost 24 years ago

Production Information Mangement

almost 24 years ago

Functionality Testing of a Multifunctional Directly Compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium

almost 24 years ago

Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives

almost 24 years ago

Validation Changes to the USP Assay Method for Ibuprofen Tablets

almost 24 years ago

Systematic Troubleshooting for LC/MS/MS

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content